You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The findings indicate that rare genetic variants in cardiomyopathy-related genes may also contribute to more common forms of heart failure.
A GWAS that incorporated magnetic resonance imaging data for UK Biobank participants led to 45 previously undetected risk loci related to dilated cardiomyopathy.
Retraction Watch reports expressions of concern have been added to two papers from Cleveland Clinic researchers.
Using samples from heart failure patients and healthy controls, researchers uncovered a gene that, when absent in mice, reduced their risk of heart failure.
Using CRISPR mouse and iPS cell models, the researchers showed that a rare maternally inherited variant is a genetic modifier of two paternally inherited variants.
In Nature this week: ash dieback disease fungal genome, and more.
Backed by €19 million in EU funding, the initiative, called [email protected], will create a research platform that could change the way cardiovascular diseases are diagnosed and treated.
A Johns Hopkins team reported its finding in JAMA Cardiology, backed by SNP array data from 21,870 participants culled from several large cardiovascular studies.
In Science this week: influence of gut microbiome metabolism on host, and more.
In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.